Targeted intrathecal drug delivery systems have long been utilized as a terminal therapeutic option for patients with chronic pain. There have been several exciting developments both in the underlying mechanisms of delivery and within the pharmacologic options available that warrant dissemination amongst pain specialists. This session will discuss the standardized approach and theory behind anatomical target, novel pharmacology in the field for both malignant and nonmalignant pain, and finally the pharmacodynamics and kinetics of intrathecal drug delivery.
Upon completion of this educational activity, participants should be able to:
- Describe the optimal anatomical target for individual medications and pharmacodynamics/kinetics of novel drug options
- Understand new evidence behind novel drugs in development
- Discuss emerging strategies and techniques for nonmalignant pain and ITP
- Viewers will gain knowledge on drug to drug interactions and systemic effect of combination ITP medication regimens.
- Accelerating Non-Pain Physician Awareness of the Role of Neuromodulation: A Discussion in Healthcare Delivery Science
- Partnering with our Patients to Optimize Outcomes
- Neuromodulation and Neurosurgical Mentorship and Educational Development
- Controversies in Targeted Drug Delivery
- Spinal Cord Stimulation Mechanisms: Results from Animal Studies
Rushna P. Ali, MD
Mark R. Jones, MD
Tammy L. Dann, DO,MPH
Tony L. Yaksh, PhD
Ann C. Shah, MD